- First case of 1,800 in vaginal mesh trial.
Reaction details (11:24)
- No immediate reaction in JNJ shares, last trade at USD 72.70 (+0.66%).
Analysis details (11:25)
- The trial relates to a vaginal mesh implant in a case brought by a South Dakota woman who blames the product for constant pain and 18 subsequent operations.
10 Jan 2013 - 11:22 - Equities - Source: Newswires
RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: